Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Coherus Biosciences, Inc. (CHRS)  
$2.27 0.10 (4.61%) as of 4:30 Fri 5/3


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 82,625,000
Market Cap: 187.56(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.59 - $8.14
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Coherus BioSciences is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of immunotherapies to treat cancer. Co. in-licensed its lead immuno-oncology product candidate, toripalimab (CHS-007), an anti-PD-1 antibody, from Shanghai Junshi Biosciences Co., Ltd. Toripalimab is being evaluated in late-stage clinical trials for the treatment of a range of tumor types. Co.'s commercial portfolio includes two U.S. Food and Drug Administration-approved biologics, including UDENYCA® (pegfilgrastim-cbqv), a biosimilar to Neulasta®, a granulocyte-colony stimulating factor and YUSIMRY™ (adalimumab-aqvh), its Humira® (adalimumab) biosimilar product.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 223,100 223,100 223,100
Total Sell Value $0 $449,770 $449,770 $449,770
Total People Sold 0 1 1 1
Total Sell Transactions 0 1 1 1
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 312
  Page 5 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Anicetti Vincent R Chief Operating Officer   •       –      –    2020-06-17 4 AS $17.22 $43,050 D/D (2,500) 48,556 0%     
   Anicetti Vincent R Chief Operating Officer   •       –      –    2020-06-17 4 OE $2.50 $6,251 D/D 2,500 51,056     -
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2020-05-20 4 AS $17.66 $22,569 D/D (1,278) 46,567 5%     
   Anicetti Vincent R Chief Operating Officer   •       –      –    2020-05-18 4 AS $17.17 $53,107 D/D (3,093) 48,556 15%     
   Anicetti Vincent R Chief Operating Officer   •       –      –    2020-05-18 4 OE $2.50 $6,251 D/D 2,500 51,056     -
   Anicetti Vincent R Chief Operating Officer   •       –      –    2020-04-20 4 AS $17.00 $87,550 D/D (5,150) 47,846 17%     
   Anicetti Vincent R Chief Operating Officer   •       –      –    2020-04-17 4 AS $15.57 $77,850 D/D (5,000) 52,996 22%     
   Anicetti Vincent R Chief Operating Officer   •       –      –    2020-04-17 4 OE $2.50 $12,503 D/D 5,000 57,996     -
   Wahlstrom Mats Director   –       •      –    2020-03-03 4 S $20.09 $2,375,409 I/I (118,066) 200,000 9%     
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2020-02-19 4 AS $22.33 $70,552 D/D (3,159) 46,841 -23%     
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2020-02-19 4 OE $10.05 $31,748 D/D 3,159 50,000     -
   Anicetti Vincent R Chief Operating Officer   •       –      –    2020-02-18 4 AS $21.64 $216,390 D/D (10,000) 52,996 -22%     
   Anicetti Vincent R Chief Operating Officer   •       –      –    2020-02-18 4 OE $2.50 $38,001 D/D 5,000 60,496     -
   Anicetti Vincent R Chief Operating Officer   •       –      –    2020-01-17 4 AS $19.56 $195,931 D/D (10,000) 57,996 -11%     
   Anicetti Vincent R Chief Operating Officer   •       –      –    2020-01-17 4 OE $2.50 $38,001 D/D 5,000 60,496     -
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2020-01-15 4 AS $19.67 $125,424 D/D (6,318) 46,841 -14%     
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2020-01-15 4 OE $10.05 $63,496 D/D 6,318 53,159     -
   Healy James Director   –       •      –    2020-01-12 4 OE $12.37 $247,400 D/D 20,000 70,086     -
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2020-01-10 4 A $0.00 $0 D/D 50,615 46,841     -
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2020-01-10 4 D $17.73 $125,475 D/D (7,077) 15,591     -
   Anicetti Vincent R Chief Operating Officer   •       –      –    2020-01-10 4 A $0.00 $0 D/D 50,816 62,996     -
   Anicetti Vincent R Chief Operating Officer   •       –      –    2020-01-10 4 D $17.73 $126,699 D/D (7,146) 31,746     -
   Vexler Vladimir Chief Scientific Officer   •       –      –    2020-01-10 4 A $0.00 $0 D/D 40,150 56,185     -
   Vexler Vladimir Chief Scientific Officer   •       –      –    2020-01-10 4 D $17.73 $61,647 D/D (3,477) 24,935     -
   Lanfear Dennis M President & CEO   •       •      –    2020-01-10 4 D $17.73 $381,479 D/D (21,516) 163,264     -
  312 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us